rs281875198
Variant summary
Our verdict is Pathogenic. Variant got 13 ACMG points: 13P and 0B. PM1PM2PM5PP2PP3_StrongPP5_Moderate
The NM_003070.5(SMARCA2):c.2255G>C(p.Gly752Ala) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 12/21 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G752R) has been classified as Likely pathogenic.
Frequency
Consequence
NM_003070.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 13 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SMARCA2 | NM_003070.5 | c.2255G>C | p.Gly752Ala | missense_variant | 15/34 | ENST00000349721.8 | |
SMARCA2 | NM_001289396.1 | c.2255G>C | p.Gly752Ala | missense_variant | 15/34 | ||
SMARCA2 | NM_139045.4 | c.2255G>C | p.Gly752Ala | missense_variant | 15/33 | ||
SMARCA2 | NM_001289397.2 | c.2255G>C | p.Gly752Ala | missense_variant | 15/33 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SMARCA2 | ENST00000349721.8 | c.2255G>C | p.Gly752Ala | missense_variant | 15/34 | 5 | NM_003070.5 | P2 |
Frequencies
GnomAD3 genomes ? Cov.: 32
GnomAD4 exome Cov.: 30
GnomAD4 genome ? Cov.: 32
ClinVar
Submissions by phenotype
not provided Pathogenic:1Other:1
not provided, no classification provided | literature only | UniProtKB/Swiss-Prot | - | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Invitae | Apr 06, 2022 | This sequence change replaces glycine, which is neutral and non-polar, with alanine, which is neutral and non-polar, at codon 752 of the SMARCA2 protein (p.Gly752Ala). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with Nicolaides-Baraitser syndrome and/or SMARCA2-related conditions (PMID: 22366787; Invitae). In at least one individual the variant was observed to be de novo. ClinVar contains an entry for this variant (Variation ID: 30019). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt SMARCA2 protein function. For these reasons, this variant has been classified as Pathogenic. - |
Nicolaides-Baraitser syndrome Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Feb 26, 2012 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at